These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 34395266)
1. 5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches. Kiesel B; Freund J; Reichert D; Wadiura L; Erkkilae MT; Woehrer A; Hervey-Jumper S; Berger MS; Widhalm G Front Oncol; 2021; 11():699301. PubMed ID: 34395266 [TBL] [Abstract][Full Text] [Related]
2. The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas. Widhalm G; Olson J; Weller J; Bravo J; Han SJ; Phillips J; Hervey-Jumper SL; Chang SM; Roberts DW; Berger MS J Neurosurg; 2020 Jul; 133(1):79-88. PubMed ID: 31075771 [TBL] [Abstract][Full Text] [Related]
3. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery. Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489 [TBL] [Abstract][Full Text] [Related]
4. The Role of 5-ALA in Low-Grade Gliomas and the Influence of Antiepileptic Drugs on Intraoperative Fluorescence. Goryaynov SA; Widhalm G; Goldberg MF; Chelushkin D; Spallone A; Chernyshov KA; Ryzhova M; Pavlova G; Revischin A; Shishkina L; Jukov V; Savelieva T; Victor L; Potapov A Front Oncol; 2019; 9():423. PubMed ID: 31192128 [No Abstract] [Full Text] [Related]
5. Influence of Corticosteroids and Antiepileptic Drugs on Visible 5-Aminolevulinic Acid Fluorescence in a Series of Initially Suspected Low-Grade Gliomas Including World Health Organization Grade II, III, and IV Gliomas. Wadiura LI; Mischkulnig M; Hosmann A; Borkovec M; Kiesel B; Rötzer T; Mercea PA; Furtner J; Hervey-Jumper S; Rössler K; Berger MS; Widhalm G World Neurosurg; 2020 May; 137():e437-e446. PubMed ID: 32045726 [TBL] [Abstract][Full Text] [Related]
6. Intra-operative visualization of brain tumors with 5-aminolevulinic acid-induced fluorescence. Widhalm G Clin Neuropathol; 2014; 33(4):260-78. PubMed ID: 24986206 [TBL] [Abstract][Full Text] [Related]
7. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors. Millesi M; Kiesel B; Woehrer A; Hainfellner JA; Novak K; Martínez-Moreno M; Wolfsberger S; Knosp E; Widhalm G Neurosurg Focus; 2014 Feb; 36(2):E11. PubMed ID: 24484249 [TBL] [Abstract][Full Text] [Related]
8. Comparing high-resolution microscopy techniques for potential intraoperative use in guiding low-grade glioma resections. Meza D; Wang D; Wang Y; Borwege S; Sanai N; Liu JT Lasers Surg Med; 2015 Apr; 47(4):289-95. PubMed ID: 25872487 [TBL] [Abstract][Full Text] [Related]
9. Macroscopic fluorescence-lifetime imaging of NADH and protoporphyrin IX improves the detection and grading of 5-aminolevulinic acid-stained brain tumors. Erkkilä MT; Reichert D; Gesperger J; Kiesel B; Roetzer T; Mercea PA; Drexler W; Unterhuber A; Leitgeb RA; Woehrer A; Rueck A; Andreana M; Widhalm G Sci Rep; 2020 Nov; 10(1):20492. PubMed ID: 33235233 [TBL] [Abstract][Full Text] [Related]
10. 5-aminolevulinic acid, fluorescein sodium, and indocyanine green for glioma margin detection: analysis of operating wide-field and confocal microscopy in glioma models of various grades. Belykh E; Bardonova L; Abramov I; Byvaltsev VA; Kerymbayev T; Yu K; Healey DR; Luna-Melendez E; Deneen B; Mehta S; Liu JK; Preul MC Front Oncol; 2023; 13():1156812. PubMed ID: 37287908 [TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement. Widhalm G; Kiesel B; Woehrer A; Traub-Weidinger T; Preusser M; Marosi C; Prayer D; Hainfellner JA; Knosp E; Wolfsberger S PLoS One; 2013; 8(10):e76988. PubMed ID: 24204718 [TBL] [Abstract][Full Text] [Related]
12. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas. Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284 [TBL] [Abstract][Full Text] [Related]
13. Visualization technologies for 5-ALA-based fluorescence-guided surgeries. Wei L; Roberts DW; Sanai N; Liu JTC J Neurooncol; 2019 Feb; 141(3):495-505. PubMed ID: 30554344 [TBL] [Abstract][Full Text] [Related]
14. Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. Sanai N; Snyder LA; Honea NJ; Coons SW; Eschbacher JM; Smith KA; Spetzler RF J Neurosurg; 2011 Oct; 115(4):740-8. PubMed ID: 21761971 [TBL] [Abstract][Full Text] [Related]
16. Double dose of 5-aminolevulinic acid and its effect on protoporphyrin IX accumulation in low-grade glioma. Suero Molina E; Black D; Kaneko S; Müther M; Stummer W J Neurosurg; 2022 Oct; 137(4):943-952. PubMed ID: 35213830 [TBL] [Abstract][Full Text] [Related]
17. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas. Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783 [TBL] [Abstract][Full Text] [Related]
18. Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors. Schwake M; Kaneko S; Suero Molina E; Müther M; Schipmann S; Köchling M; Brentrup A; Stummer W Acta Neurochir (Wien); 2019 Oct; 161(10):2099-2105. PubMed ID: 31435824 [TBL] [Abstract][Full Text] [Related]
19. What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas? Hadjipanayis CG; Widhalm G; Stummer W Neurosurgery; 2015 Nov; 77(5):663-73. PubMed ID: 26308630 [TBL] [Abstract][Full Text] [Related]
20. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas. Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]